Lungs Clear but Still Not Well Post-COVID Months after diagnosis, fatigue is common but lung fibrosis is not Jan 08, 2021
FDA Panel Backs Entresto, Spironolactone for Broader HF Use But committee stops short of advocating categorical approval for HFpEF Dec 16, 2020
FDA Review Gives Rosy Outlook for What Could Be First HFpEF Drugs Advisory committee weigh unusual moves for Entresto and spironolactone Dec 14, 2020
Heart Failure Seen in Baby With COVID-19 Full recovery made after acute decompensated presentation Dec 02, 2020
Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
COVID's Heart Complications Modest in Large Registry Obese and minority groups at higher risk, though, analyses affirm Nov 18, 2020
Sotagliflozin Prevents Heart Events in Acute HF, Chronic Kidney Disease Two trials show some tantalizing signals for HFpEF and stroke Nov 17, 2020
Skip Rhythm Drugs, Go Straight to Cryoablation for Afib Two trials support shift into first-line strategy Nov 16, 2020
After Stenting, Aspirin May Be Just as Good Solo After 1-Month DAPT Randomized trial makes a case for dropping the P2Y12 inhibitor Nov 15, 2020
SAMSON Trial: 90% of Statin Complaints Are Nocebo Effect Placebo challenge had positive results for many patients, though Nov 15, 2020